Your browser doesn't support javascript.
loading
Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer.
Sanoff, Hanna K; Moon, Dominic H; Moore, Dominic T; Boles, Jeremiah; Bui, Courtney; Blackstock, William; O'Neil, Bert H; Subramaniam, Somasundaram; McRee, Autumn J; Carlson, Cheryl; Lee, Michael S; Tepper, Joel E; Wang, Andrew Z.
Afiliación
  • Sanoff HK; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Department of Medicine, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC.
  • Moon DH; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC.
  • Moore DT; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.
  • Boles J; Rex Cancer Center, Raleigh, NC.
  • Bui C; Rex Cancer Center, Raleigh, NC.
  • Blackstock W; Wake Forest Cancer Center, Winston-Salem, NC.
  • O'Neil BH; Indiana University, Indianapolis, IN.
  • Subramaniam S; Swedish Cancer Institute, Seattle, WA.
  • McRee AJ; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Department of Medicine, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC.
  • Carlson C; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Department of Medicine, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC.
  • Lee MS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Department of Medicine, Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC.
  • Tepper JE; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC.
  • Wang AZ; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC; Laboratory of Nano- and Translational Medicine, Carolina Center for Cancer Nanotechnology Excellent, Carolina Institute of Nanomedic
Nanomedicine ; 18: 189-195, 2019 06.
Article en En | MEDLINE | ID: mdl-30858085
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Camptotecina / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadyuvante / Ciclodextrinas / Nanopartículas / Capecitabina Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nanomedicine Asunto de la revista: BIOTECNOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Nueva Caledonia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Camptotecina / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadyuvante / Ciclodextrinas / Nanopartículas / Capecitabina Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nanomedicine Asunto de la revista: BIOTECNOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Nueva Caledonia Pais de publicación: Estados Unidos